🇺🇸 FDA

Drug profile · INN

sodium monofluorophosphate

EXTRA-STRENGTH AIM

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

sodium monofluorophosphate (EXTRA-STRENGTH AIM) is an FDA-listed pharmaceutical active ingredient. Route of administration: dental. Current US regulatory status: approved.

Key facts

INN sodium monofluorophosphate
Brand EXTRA-STRENGTH AIM
Route DENTAL
Formulation PASTE

Frequently asked questions

What is sodium monofluorophosphate?

sodium monofluorophosphate (EXTRA-STRENGTH AIM) is an FDA-listed pharmaceutical active ingredient. Route of administration: dental. Current US regulatory status: approved.

What is the brand name for sodium monofluorophosphate?

EXTRA-STRENGTH AIM is a marketed brand name for sodium monofluorophosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium monofluorophosphate?

sodium monofluorophosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.